Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.165 USD | -3.51% | -6.89% | +110.26% |
May. 14 | Nuvation Bio Q1 Loss Narrows; Shares Fall After Hours | MT |
May. 14 | Nuvation Bio Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+110.26% | 811M | |
+63.99% | 62.59B | |
-1.32% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.40% | 26.21B | |
-21.84% | 19.09B | |
+4.98% | 13.08B | |
+25.22% | 12.26B | |
+28.21% | 12.05B |
- Stock Market
- Equities
- NUVB Stock
- News Nuvation Bio Inc.
- Nuvation Bio Doses First Patient in Phase 1/2 Study of Advanced Solid Tumor Treatment